Global Stem Cell Market is Projected to Value Over USD 15.5 Billion by 2026 End

  • 12 Aug 2019

Global Stem Cell Market is estimated to value over USD 15.5 billion by 2026 end and is expected to register a CAGR over 8.5% during the forecast period 2019 to 2026.

 

Stems cells have garnered significant traction from the scientist and research community despite it being a controversial concept. The tremendous success achieved by regenerative medicine coupled with accelerating growth in current research activities are a few integral factors liable for the market to proliferate.

 

Advanced research in the development of biomaterial polymeric systems has resulted in a significant rise in recent years. These systems are instrumental in aiding the survival of stem cells which has boosted the market growth. Furthermore, advancements in the treatment of damaged tissues and diseased organs coupled with an increasing demand for regenerative medicines has propelled the market growth significantly.

 

The adoption of stem cell has uncovered new opportunities for applications such as wound healing therapy which has assisted in the further augmentation of the market. The increased supply of biomaterial development used in stem cell transplantation and induced pluripotent stem cells (iPSCs) has revolutionised the stem cell sector. Such innovations allow researchers to create pluripotent stem cells from adult somatic cells which aid in preserving genetic information in these cells thus boosting the market growth.

 

The personalised medicine approach which dominated the medicine sector for years has been slowly surpassed by clinical trial approach owing to an increase in research activities on stem cells. Additionally, it is possible to treat disorders that were previously untreatable owing to the adoption of stem cells. According to the WideCells Group, there has been an increase of over 295% in the number of diseases that can be treated by stem cells between 2005 and 2013 and this has assisted in the market augmentation.

 

The key opportunity for the market to thrive is to utilise the full potential of stem cells through extensive research. Many companies are providing funds for research activities focussed exclusively on the applications of regenerative medicine. Massive investments from funding bodies to accelerate research and understand the importance of stem cells shall bolster market growth.

 

However, public perception regarding stem cell research coupled with ethical and societal concerns at different research phases is projected to hamper the execution of stem cell therapy significantly.

 

Regenerative Medicine Has Potential of Changing the Face of the Medical Sector

The iPSCs segment is predicted to showcase remarkable growth during the forecast period thus providing scope for the overall development in the medicals sector. Growing research activities in the usage of stem cells for organoid generation and drug screenings have emerged as integral driving factors responsible for the growth of this segment.

 

Regenerative medicine’s use for formulating early-intervention treatments to cure traumatic injuries and degenerative diseases. Moreover, the widespread availability of regenerative medicine is propelling market growth further. The neurology segment accounted for the largest market share regarding regenerative medicine revenue which is related to the increasing number of FDA approved products. A strong portfolio for cancer therapies is projected to boost the growth of oncology regenerative medicine.

 

Cell acquisition is the fundamental step which has led to the dominance of this segment and it is expected to exhibit similar growth trends during the forecast period. This is due to rising awareness regarding the importance of stem cells. The most used body part for cell acquisition is the bone marrow due to its capability of producing new cells at a faster rate. Furthermore, cell originated from bone marrow are more concentrated as compared to other sites of origin.

 

The North America region is estimated to lead the market over the forecast period due to the persistent efforts from government and private sectors for establishing well-defined business models in the United States and Canada.

 

The key market players include STEMCELL Technologies Inc., Celegene Corp., Osiris Therapeutics Inc., BIOTIME Inc., Advanced Cell Technology Inc. Cytori Therapeutics, Human Longevity Inc., Cynata, Promethera Biosciences and Mesoblast.

 

Market Segmentation:

By Product

·     Adult Stem Cells

·     Human Embryonic Stem Cells

·     Induced Pluripotent Stem Cells (iPSCs)

·     Very Small Embryonic-like Stem Cells

 

By Application

·     Regenerative Medicine

o  Neurology

o  Orthopaedics

o  Oncology

o  Haematology

o  Cardiovascular and Myocardial Infraction

o  Injuries

o  Diabetes

o  Liver Disorder

o  Incontinence

o  Others

 

·     Drug Discovery & Development

 

By Technology

·     Cell Acquisition

·     Bone Marrow Harvest

·     Umbilical Blood Cord

·     Apheresis

·     Cell Production

·     Therapeutic Cloning

·     In vitro Fertilization

·     Cell Culture

·     Isolation

·     Cryopreservation

·     Expansion and Sub-culture

 

By Therapy

·     Autologous

·     Allogenic

 

By Region

·     North America

·     Europe

·     Asia Pacific

·     Latin America

·     Middle East & Africa

 

Competitive Landscape:

·     Tier 1 players- established companies in the market with a major market share 

·     Tier 2 players 

·     Emerging players which are growing rapidly 

·     New Entrants

 

FutureWise Key Takeaways:

·     Growth prospects for stem cell market 

·     SWOT analysis 

·     Key trends in stem cell regeneration techniques

·     Key data-points affecting market growth 

  

Objectives of the Study:

·     To provide with an exhaustive analysis on the stem cell market by technology, by product, by application, by therapy and by region

·     To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

·     To evaluate and forecast micro-markets and the overall market

·     To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa

·     To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

·     Profiling of companies to evaluate their market shares, strategies, financials and core competencies

 

Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com